No disclosed counterparties: CSW, DOV.
| Stage | CSW | % of rev | DOV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $361M | 100.00% | $2.2B | 100.00% | DOV ×6.18 |
| Gross profit | $152M | 42.03% | $903M | 40.44% | CSW +1.6pp |
| Operating income | $76M | 20.90% | $419M | 18.77% | CSW +2.1pp |
| Pre-tax income | $63M | 17.46% | $421M | 18.83% | DOV +1.4pp |
| Net income | $48M | 13.25% | $333M | 14.92% | DOV +1.7pp |
| Stage | CSW | DOV | Gap · A − B |
|---|---|---|---|
| Revenue | $361M100.00% | $2.2B100.00% | DOV ×6.18 |
| Gross profit | 42.03%$152M | 40.44%$903M | CSW +1.6pp |
| Operating income | 20.90%$76M | 18.77%$419M | CSW +2.1pp |
| Pre-tax income | 17.46%$63M | 18.83%$421M | DOV +1.4pp |
| Net income |
| 13.25%$48M |
| 14.92%$333M |
| DOV +1.7pp |